NCT02994381View on ClinicalTrials.gov

A Single Dose Oral Excretion Balance Study of [14C]-RPC1063 in Healthy Male Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions

Healthy Volunteers

Interventions

DRUG

RPC1063

Trial Locations (1)

NG11 6JS

Quotient Clinical, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celgene

INDUSTRY

NCT02994381 - A Single Dose Oral Excretion Balance Study of [14C]-RPC1063 in Healthy Male Adults | Biotech Hunter | Biotech Hunter